Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2014
03/12/2014CN103627709A Deoxyribozyme capable of suppressing genetic expression of vascular endothelial growth factor
03/12/2014CN103627006A Degradable TPGS-PEI (Tocopherol Polyethylene Glycol Succinate-Polyethyleneimine) graft polymer, preparation method and application thereof in gene medicine transfer
03/12/2014CN103627004A Double-hydrophilic hyperbranched polymer, as well as preparation method and application thereof
03/12/2014CN103626996A Guanidinylation SS-PAAs polymer as well as preparation and application thereof
03/12/2014CN103626877A NY-ESO-1-containing fusion protein as well as preparation method and application thereof
03/12/2014CN103626865A Secreted protein with chemotactic activity, as well as coding sequence and medicament usage thereof
03/12/2014CN103626863A Oligopeptide capable of inhibiting growth of cancer cells and encoding gene thereof
03/12/2014CN103626846A Ligand polypeptide specifically combined with MDSCs (Myeloid-Derived Suppressor Cells) and drug delivery system
03/12/2014CN103623431A Application of miR181s in preparing drug for treating acute enteritis
03/12/2014CN103623430A Preparation method and application of targeted co-supported drug delivery system nano-particles based on polylactic-co-glycolic acid
03/12/2014CN103623429A Application of LincRNA (large intergenic non-coding RNA) in preparation of medicine for controlling tumor treatment drug resistance of methotrexate
03/12/2014CN103623428A Transformation method and application of recombinant virus containing ER beta
03/12/2014CN103623427A Applications of human USP14 gene and related medicines
03/12/2014CN103623426A Applications of human PPP5C gene and related medicines
03/12/2014CN103623425A Medicament for inhibiting neovascularization diseases angiogenesis by using dual-target antagomir
03/12/2014CN103623424A Brain targeting gene delivery system based on polymethacrylate
03/12/2014CN103623417A Application of functionalized polyamide-amine dendrimer nanocomposite
03/12/2014CN103623416A Targeted ligand-PEG (polyethylene glycol)-cholesterol/tocopherol derivative, and preparation method and application of derivative
03/12/2014CN102965376B N-(3-oxo-dodecanoyl)-L-homoserine lactone aptamer, its screening method and application
03/12/2014CN102895677B Multivalent carrier vaccine for shrimp and application thereof
03/12/2014CN102836420B Methods and compositions involving MDA-7
03/12/2014CN102757938B Application of VSTM1 protein in preparation of product for promoting differentiation of leukemic cells
03/12/2014CN102580118B Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine
03/12/2014CN102552901B Application of fullerene derivative to prepare gene transmission vector
03/12/2014CN102533966B Micro-RNA-based methods and compositions for diagnosis, prognosis and treatment of breast cancer
03/12/2014CN102272179B Multiblock copolymers
03/12/2014CN102266555B Method for preparing grass carp reovirus (GCRV) gene engineering vaccines
03/12/2014CN102229961B Conditionally replicating oncolytic adenoviral vector used for expressing two exogenous genes and modified by small peptide, construction method and application thereof
03/12/2014CN102151337B Compositions and methods for regulated protein expression in gut
03/12/2014CN102143761B Agent for treating myelofibrosis
03/12/2014CN102112146B Immunity inducer
03/12/2014CN102085377B Immunogenic composition and methods
03/12/2014CN102071219B Improved adenovirus vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome)
03/12/2014CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity
03/12/2014CN101880688B Method for selectively replicating replication-defective adenovirus and application
03/12/2014CN101541960B Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing same
03/11/2014US8669239 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8669235 Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b
03/11/2014US8669101 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
03/11/2014US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
03/11/2014US8669091 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
03/11/2014US8668898 Low radiocarbon dietary supplements and foods and methods of making and using same
03/11/2014CA2562552C Hybrid recombinases for genome manipulation
03/11/2014CA2501851C Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/06/2014WO2014036524A2 Genetically modified msc and therapeutic methods
03/06/2014WO2014036488A1 Methods for producing high-fidelity autologous idiotype vaccines
03/06/2014WO2014036468A2 Aav mediated aquaporin gene transer to treat sjogren's syndrome
03/06/2014WO2014036014A2 Dominant negative transcription factor for antagonizing oncogenic transcription factors via multimerization
03/06/2014WO2014035457A1 Dna plasmids with improved expression
03/06/2014WO2014034934A1 Oligonucleotide
03/06/2014WO2014034754A1 Psf1-derived peptide
03/06/2014WO2014034735A1 Dna vaccine containing vegf-specific epitope and/or angiopoietin-2-specific epitope
03/06/2014WO2014034609A1 P53 family chimeric molecule and use thereof
03/06/2014WO2014033095A1 Retinal off circuit-specific promoter
03/06/2014WO2014032953A1 Formulation for the delivery of nucleotide sequences that can modulate endogenous interfering rna mechanisms
03/06/2014WO2014009589A3 Use of nuclear localization signals of bacteriophage proteins as gene transfer vehicle
03/06/2014WO2013181666A3 Antisense compounds targeting genes associated with fibronectin
03/06/2014WO2013170086A3 Formulations for the delivery of active ingredients
03/06/2014WO2013158782A3 Methods and compositions for treating cardiac arrhythmias
03/06/2014WO2013063468A8 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140065206 Agents that Reduce Neuronal Overexcitation
03/06/2014US20140065204 Compositions and methods for delivering nucleic acid to a cell
03/06/2014US20140065189 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
03/06/2014US20140065140 Cancer treatment using viruses and camptothecins
03/06/2014US20140065105 Simian Adenovirus Nucleic Acid and Amino Acid Sequences, Vectors Containing Same, and Methods of Use
03/06/2014US20140065093 Compositions For Achieving A Therapeutic Effect In An Anatomical Structure
03/05/2014EP2703487A1 Peptide for inducing regeneration of tissue and use thereof
03/05/2014EP2702999A1 Brain-targeting functional nucleic acid and use thereof
03/05/2014EP2701746A2 A method for manufacturing pegylated oligonucleotides
03/05/2014EP2701745A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
03/05/2014EP2701732A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
03/05/2014EP2701723A2 Dna aptamers for promoting remyelination
03/05/2014EP2701722A2 Human myeloid derived suppressor cell cancer markers
03/05/2014EP2701686A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/05/2014CN103620057A Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)
03/05/2014CN103619355A Apoptosis-inducing agent
03/05/2014CN103619352A Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
03/05/2014CN103614416A Recombinant oncolytic adenovirus carrying human cell-penetrating peptide p53 and GM-CSF gene, and uses thereof
03/05/2014CN103614414A AFP (Alpha Fetoprotein) and IL-2 (Interleukin-2) double-gene co-expressing recombinant vector as well as preparation method and application thereof
03/05/2014CN103614387A Optimized porcine circovirus type-2 Cap protein gene as well as recombinant plasmid application thereof
03/05/2014CN103614379A FoxQ1 gene-targeting interfering siRNA (Small Interfering Ribonucleic Acid) and application thereof to resisting nonsmall-cell lung cancer
03/05/2014CN103614375A Composition and method for inhibiting expression of PCSK9 gene
03/05/2014CN103614329A Construction method and application of DNA (Deoxyribonucleic Acid) vaccine for avian leukosis virus subgroup J
03/05/2014CN103613681A Tea polysaccharide derivative and preparation method thereof
03/05/2014CN103613644A Small peptide lactotransferrin (LTF) with anti-tumor effect and application thereof
03/05/2014CN103613516A Preparation method of Gemini type cationic lipoid and application of Gemini type cationic lipoid in drug or gene transfer
03/05/2014CN103611169A Immune magnetic albumin nanosphere with targeting and preparation method thereof
03/05/2014CN103611168A Composite magnetic nanoparticles for targeted therapy of liver cancer and preparation method thereof
03/05/2014CN103611167A Application of miR-106a in inhibiting expression and glucose uptake of glioma cell SLC2A3
03/05/2014CN103611151A Application of circumsporozoite protein polypeptide CSP I-plus of plasmodium in preparing anti-malarial medicine
03/05/2014CN103611150A Application of circumsporozoite protein polypeptide CSP I-plus of plasmodium in preparing medicine for resisting hepatitis virus
03/05/2014CN103045630B Encephalitis virus protein and encoding gene and application thereof
03/05/2014CN103014063B Encephalitis virus protein as well as coding gene and application thereof
03/05/2014CN103014044B Encephalitis virus protein as well as coding gene and application thereof
03/05/2014CN102940885B Method for improving efficiency of meso-porous silicon nano materials entering into cells by utilizing cationic liposome
03/05/2014CN102690826B shRNA for specifically reducing human Aurora-A gene expression and application thereof
03/05/2014CN102617712B Polypeptide for effectively restraining activity of influenza virus polymerase
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 870